Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.58 |
| ▸ | ESR1 | P03372 | 2/20 | 0.58 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.58 |
| ▸ | TACR2 | P21452 | 2/20 | 0.58 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.58 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.58 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | SHBG | P04278 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.58 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.58 |
| ▸ | HTR2C | P28335 | 1/20 | 0.58 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | TST | Q16762 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4532142 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL4527877 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL4203952 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL1301381 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL4534627 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL195157 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL2733171 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL4532942 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL4528217 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 | |
| SCHEMBL197275 | 1.00 | CA2 (0.66) | CA2ALDH1A1ESR1ADRA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102471721-A | Hydrodynamic disk drive spindle motor with hydro bearing having lubricant containing conductivity inducing agent | SEAGATE TECHNOLOGY LLC | 2012-05-23 | — | — | CN | claimed |
| CN-119997951-A | Method for preventing, alleviating and/or treating PTGS 2-induced skin disorders and related dysfunctions | 西姆莱斯股份公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-119968452-A | Perfume mixture (VI) | 西姆莱斯股份公司 | 2025-05-09 | — | — | CN | disclosed |
| EP-4532647-A1 | COMPOSITION, ITS USE AND A PROCESS FOR CLEANING SUBSTRATES COMPRISING COBALT AND COPPER | BASF SE (DE) | 2025-04-09 | — | — | EP | disclosed |
| CN-119790128-A | Perfume mixture (III) | 西姆莱斯股份公司 | 2025-04-08 | — | — | CN | disclosed |
| CN-119317696-A | Perfume mixture (V) | 西姆莱斯股份公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-119317695-A | Perfume mixture (V) | 西姆莱斯股份公司 | 2025-01-14 | — | — | CN | disclosed |
| CN-119255980-A | Perfume with cyclopropyl structure | 西姆莱斯股份公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-117682945-B | Preparation method of polidocanol and intermediate thereof | 苏州博研医药科技有限公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-117682945-A | Preparation method of polidocanol and intermediate thereof | 苏州博研医药科技有限公司 | 2024-03-12 | — | — | CN | disclosed |
| US-20110014189-A1 | Stable pharmaceutical composition comprising at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents | ADOCIA (FR) | 2011-01-20 | — | — | US | disclosed |
| US-7534554-B2 | Chemically amplified resist composition and manufacturing method of semiconductor integrated circuit device with such chemically amplified resist composition | NEC ELECTRONICS CORPORATION (JP) | 2009-05-19 | — | — | US | disclosed |
| US-20080233518-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND MANUFACTURING METHOD OF SEMICONDUCTOR INTEGRATED CIRCUIT DEVICE WITH SUCH CHEMICALLY AMPLIFIED RESIST COMPOSITION | NEC ELECTRONICS CORPORATION (JP) | 2008-09-25 | — | — | US | disclosed |
| US-7396633-B2 | Damascene process; forming connectors; exposure; development; using acid generator, quencher and buffer | NEC ELECTRONICS CORPORATION (JP) | 2008-07-08 | — | — | US | disclosed |
| US-20080081772-A1 | Mechanical Element | FUJIFILM CORPORATION (JP) | 2008-04-03 | — | — | US | disclosed |
| US-20070249762-A1 | Rubber modified asphalt cement compositions and methods | RAM TECHNOLOGIES GROUP, INC. (US) | 2007-10-25 | — | — | US | disclosed |
| US-20070122730-A1 | Method for producing binder resin, particulate resin dispersion and method for producing same, electrostatic image development toner and method for producing same, electrostatic image developer, and image forming method | FUJI XEROX CO., LTD. (JP) | 2007-05-31 | — | — | US | disclosed |
| US-7074846-B2 | Rubber modified asphalt cement compositions and methods | RAM TECHNOLOGIES, INC. (US) | 2006-07-11 | — | — | US | disclosed |
| US-20040259029-A1 | Chemically amplified resist composition and manufacturing method of semiconductor integrated circuit device with such chemically amplified resist composition | NEC ELECTRONICS CORPORATION (JP) | 2004-12-23 | — | — | US | disclosed |
| US-20040225036-A1 | Rubber modified asphalt cement compositions and methods | RAM TECHNOLOGIES GROUP, INC. | 2004-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110014189-A1 | Stable pharmaceutical composition comprising at least one monoclonal antibody and at least one amphiphilic polysaccharide comprising hydrophobic substituents | ALG1, SIGLEC7, PIGS | CA2 2693/4885ALDH1A1 1444/4885ESR1 4775/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.